Everyday heart health, carefully made
Heart health is not one pathway. A credible product strategy begins by defining whether the brief concerns vascular function, normal platelet aggregation and blood flow, triglyceride management or cholesterol management.
MORETH develops heart-health products in Malaysia by matching each objective to the relevant ingredient evidence, daily intake, delivery format, safety review, stability controls and destination-market claim pathway.
What defines the category
One category, distinct pathways.
These are related cardiovascular objectives, not interchangeable claims.
Ingredient familiarity alone is not a product strategy.
The formulation follows the evidence. The studied ingredient form, specification, daily intake, target population and delivery format must be translated into a manufacturable product without weakening the scientific rationale.
Where expertise counts
Before a heart-health formulation is finalised, our team assesses four decisions:
- 01EndpointThe primary objective and measurable endpoint: vascular or endothelial function, normal platelet aggregation and blood flow, triglycerides or cholesterol
- 02Evidence matchIngredient identity and evidence match: L-arginine dose and population, the exact standardized tomato preparation, EPA and DHA profile, or sterol, stanol and beta-glucan specification
- 03DeliveryDelivery and bioavailability: gram-level amino acids and fibres require different formats from lipophilic omega-3 oils
- 04SafetySafety and use context: target consumers, cumulative intake, concurrent product use and required warnings
Stability is designed around the active and format—from oxidative protection for omega-3 oils to potency and specification checks through shelf life. Settling the objective, evidence and claim pathway first prevents a formula becoming a collection of familiar ingredients without a coherent consumer proposition.
From Malaysia to APAC
The classification and claim boundary moves
A heart-health product may fall under food, supplement or other regulated-product frameworks, depending on the market, formulation, dosage form, presentation and claims. The same evidence may support different wording—or no consumer claim—across destinations.
Adapted per destination
We assess ingredient eligibility, daily use levels, warnings, claim language, stability expectations and documentation before the formulation and artwork are finalised—enabling controlled regional variants without rebuilding the range market by market.